New Delhi: The DCGI (Drugs Controller General of India), on Tuesday, gave restricted emergency use authorization to Bharat Biotech’s Covaxin as a COVID-19 vaccine for children between the age of 6-12 years, news agency ANI reported citing sources. Besides, the drug regulator also granted emergency use authorization to Corbevax for children between the age of 5-12 years and ZycovD (Zydus Cadila vaccine) for children above the age of 12 years.
In March, the Centre had told the Delhi High Court that it will be filing a status report regarding the vaccination of children below 12 years of age. The government has vehemently stated that 100 per cent vaccination is its top priority in its fight against coronavirus in the country. Accordingly, the government started the vaccination of children above 12 years of age on March 16. Currently, children between 12 and 14 years of age are being administered Corbevax.